Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranscription corepressor activity

CIR1 BCL11A CBFA2T3 PPP1R13L MIDEAS MIER1 TRIM28 INSM2 ZNF541

1.71e-052291289GO:0003714
GeneOntologyMolecularFunctioncytoskeletal protein binding

FLII HIP1 CALD1 NDE1 MAP6 MARK1 GTSE1 APC MAST2 ABLIM3 RGS14 PDLIM3 NKD2 MAP1S FHOD1 MARK2 MYO18B CAMSAP1 AKAP1

7.36e-05109912819GO:0008092
GeneOntologyMolecularFunctionhistone modifying activity

BRPF3 EYA1 FBXL19 MIER1 JARID2 BUB1 KAT6B UTY

1.16e-042291288GO:0140993
GeneOntologyMolecularFunctionprotein kinase activity

MARK1 CAMK2G MAP3K14 FGFRL1 MAST2 STK35 TRIM28 BUB1 PRKAB1 CHEK2 MARK2 ALK WNK2

1.28e-0460012813GO:0004672
GeneOntologyMolecularFunctionmicrotubule binding

NDE1 MAP6 GTSE1 APC MAST2 RGS14 MAP1S CAMSAP1 AKAP1

1.68e-043081289GO:0008017
GeneOntologyMolecularFunctionmolecular adaptor activity

HIP1 CIR1 ZC3H18 BCL11A FBXL19 CBFA2T3 PPP1R13L MIDEAS MIER1 AKAP12 AXIN1 JARID2 RGS14 SHANK2 NKD2 TRIM28 INSM2 KAT6B AKAP1 ZNF541

3.92e-04135612820GO:0060090
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

HIP1 CIR1 ZC3H18 BCL11A FBXL19 CBFA2T3 PPP1R13L MIDEAS MIER1 AKAP12 AXIN1 JARID2 RGS14 SHANK2 TRIM28 INSM2 KAT6B ZNF541

4.34e-04116012818GO:0030674
GeneOntologyMolecularFunctionprotein serine kinase activity

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 WNK2

5.61e-043631289GO:0106310
GeneOntologyMolecularFunctionprotein serine/threonine kinase activity

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 PRKAB1 CHEK2 MARK2 WNK2

6.07e-0444612810GO:0004674
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

MARK1 CAMK2G MAP3K14 FGFRL1 MAST2 STK35 TRIM28 BUB1 PRKAB1 CHEK2 MARK2 ALK WNK2

6.37e-0470912813GO:0016773
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

RNGTT MARK1 CAMK2G MAP3K14 FGFRL1 MAST2 STK35 POLR3C TRIM28 BUB1 PRKAB1 CHEK2 MARK2 ALK WNK2

9.95e-0493812815GO:0016772
GeneOntologyMolecularFunctiontranscription coregulator activity

CIR1 BCL11A FBXL19 CBFA2T3 PPP1R13L MIDEAS MIER1 TRIM28 INSM2 KAT6B ZNF541

9.96e-0456212811GO:0003712
GeneOntologyMolecularFunctionhistone demethylase activity

FBXL19 JARID2 UTY

1.01e-03311283GO:0032452
GeneOntologyMolecularFunctionprotein demethylase activity

FBXL19 JARID2 UTY

1.11e-03321283GO:0140457
GeneOntologyMolecularFunctionkinase activity

MARK1 CAMK2G MAP3K14 FGFRL1 MAST2 STK35 TRIM28 BUB1 PRKAB1 CHEK2 MARK2 ALK WNK2

1.26e-0376412813GO:0016301
GeneOntologyMolecularFunctionhistone H3K14 acetyltransferase activity

BRPF3 KAT6B

1.43e-0391282GO:0036408
GeneOntologyMolecularFunctiontubulin binding

NDE1 MAP6 GTSE1 APC MAST2 RGS14 MAP1S CAMSAP1 AKAP1

1.77e-034281289GO:0015631
GeneOntologyMolecularFunctionunmethylated CpG binding

FBXL19 CXXC1

1.77e-03101282GO:0045322
GeneOntologyBiologicalProcesschromatin organization

SAMD1 BRPF3 ING5 CHD2 CHD3 EYA1 FBXL19 MIER1 AXIN1 PHF1 JARID2 PWWP2B KANSL1 TRIM28 CTR9 BUB1 KAT6B UTY

1.34e-0589613018GO:0006325
GeneOntologyBiologicalProcessprotein-DNA complex organization

BDP1 SAMD1 BRPF3 ING5 CHD2 CHD3 EYA1 FBXL19 MIER1 AXIN1 PHF1 JARID2 PWWP2B KANSL1 TRIM28 CTR9 BUB1 KAT6B UTY

1.62e-0599913019GO:0071824
GeneOntologyBiologicalProcesschromatin remodeling

SAMD1 BRPF3 CHD2 CHD3 EYA1 FBXL19 MIER1 AXIN1 PHF1 JARID2 PWWP2B TRIM28 CTR9 BUB1 KAT6B UTY

1.76e-0574113016GO:0006338
GeneOntologyBiologicalProcessmicrotubule cytoskeleton organization

SPAG1 NDE1 MAP6 MARK1 APC CHD3 SPECC1L EYA1 AXIN1 DNAAF8 RGS14 MAP1S CHEK2 MARK2 CAMSAP1

4.92e-0572013015GO:0000226
GeneOntologyBiologicalProcessnegative regulation of DNA-templated transcription

ZMYND15 SAMD1 TBX3 CIR1 CHD3 BCL11A CBFA2T3 PPP1R13L MIDEAS MIER1 MAGEF1 CIC E2F8 AXIN1 JARID2 TRIM28 CTR9 ATOH8 MEPCE INSM2 KAT6B ZNF541

6.06e-05139913022GO:0045892
GeneOntologyBiologicalProcessnegative regulation of RNA biosynthetic process

ZMYND15 SAMD1 TBX3 CIR1 CHD3 BCL11A CBFA2T3 PPP1R13L MIDEAS MIER1 MAGEF1 CIC E2F8 AXIN1 JARID2 TRIM28 CTR9 ATOH8 MEPCE INSM2 KAT6B ZNF541

7.02e-05141313022GO:1902679
GeneOntologyBiologicalProcessmicrotubule-based process

SPAG1 NDE1 MAP6 MARK1 GTSE1 APC CHD3 SPECC1L EYA1 TTLL8 AXIN1 DNAAF8 RGS14 MAP1S CHEK2 MARK2 BSN CAMSAP1

1.16e-04105813018GO:0007017
GeneOntologyBiologicalProcessregulation of microtubule depolymerization

APC SPECC1L MAP1S CAMSAP1

1.40e-04421304GO:0031114
GeneOntologyCellularComponentMOZ/MORF histone acetyltransferase complex

BRPF3 ING5 KAT6B

8.08e-0671303GO:0070776
GeneOntologyCellularComponentH3 histone acetyltransferase complex

BRPF3 ING5 KAT6B

1.29e-0581303GO:0070775
GeneOntologyCellularComponenthistone methyltransferase complex

CXXC1 PHF1 JARID2 KANSL1 UTY

1.05e-04751305GO:0035097
GeneOntologyCellularComponentactin cytoskeleton

FILIP1 FLII HIP1 CALD1 SPECC1L ABLIM3 NPFFR2 PDLIM3 TJP1 FHOD1 MARK2 MYO18B

2.57e-0457613012GO:0015629
GeneOntologyCellularComponentnuclear body

AFF3 CIR1 TFIP11 CHD3 ZC3H18 BCL11A EYA1 STK35 CXXC1 YARS2 RGS14 CTR9 ATOH8 HACE1 CHEK2

4.99e-0490313015GO:0016604
GeneOntologyCellularComponentmethyltransferase complex

CXXC1 PHF1 JARID2 KANSL1 UTY

5.75e-041081305GO:0034708
DomainZnf_PHD-finger

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 KAT6B

3.00e-09791269IPR019787
DomainPHD

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 KAT6B

8.75e-09891269SM00249
DomainZnf_PHD

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 KAT6B

1.07e-08911269IPR001965
DomainZinc_finger_PHD-type_CS

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28

1.25e-08651268IPR019786
DomainZF_PHD_2

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 KAT6B

1.56e-08951269PS50016
DomainZF_PHD_1

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 KAT6B

1.72e-08961269PS01359
DomainPHD

BRPF3 ING5 DIDO1 CHD3 CXXC1 PHF1 TRIM28 KAT6B

3.96e-08751268PF00628
DomainZnf_FYVE_PHD

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 BSN KAT6B

5.93e-0814712610IPR011011
DomainELM2_dom

MIDEAS MIER1 ZNF541

8.16e-05131263IPR000949
DomainELM2

MIDEAS MIER1 ZNF541

8.16e-05131263PF01448
DomainELM2

MIDEAS MIER1 ZNF541

8.16e-05131263PS51156
DomainELM2

MIDEAS MIER1 ZNF541

8.16e-05131263SM01189
DomainMYB_LIKE

BDP1 MIDEAS MIER1 ZNF541

1.22e-04381264PS50090
Domain-

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 BSN KAT6B PDZRN3

2.33e-04449126113.30.40.10
DomainMARK/par1

MARK1 MARK2

2.69e-0441262IPR033624
DomainZnf_RING/FYVE/PHD

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 BSN KAT6B PDZRN3

2.81e-0445912611IPR013083
DomainSH3_2

MIA3 TSPOAP1 RUSC2 SHANK2 TJP1

2.90e-04861265PF07653
DomainSH3_2

MIA3 TSPOAP1 RUSC2 SHANK2 TJP1

2.90e-04861265IPR011511
DomainSANT

BDP1 MIDEAS MIER1 ZNF541

3.58e-04501264SM00717
DomainSANT/Myb

BDP1 MIDEAS MIER1 ZNF541

4.16e-04521264IPR001005
DomainKA1

MARK1 MARK2

4.46e-0451262PF02149
DomainKA1_dom

MARK1 MARK2

4.46e-0451262IPR001772
DomainKA1

MARK1 MARK2

4.46e-0451262PS50032
Domain-

MARK1 MARK2

4.46e-04512623.30.310.80
DomainSANT_dom

MIDEAS MIER1 ZNF541

6.96e-04261263IPR017884
DomainSer/Thr_kinase_AS

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 WNK2

7.13e-043571269IPR008271
DomainS_TKc

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 WNK2

7.42e-043591269SM00220
DomainPROTEIN_KINASE_ST

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 WNK2

7.87e-043621269PS00108
DomainSANT

MIDEAS MIER1 ZNF541

8.68e-04281263PS51293
DomainKA1/Ssp2_C

MARK1 MARK2

9.27e-0471262IPR028375
DomainPROTEIN_KINASE_ATP

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 ALK WNK2

1.11e-0345912610PS00107
DomainPkinase

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 WNK2

1.13e-033811269PF00069
DomainCa/CaM-dep_Ca-dep_prot_Kinase

MARK1 CAMK2G CHEK2 MARK2

1.22e-03691264IPR020636
DomainMyb_DNA-binding

MIDEAS MIER1 ZNF541

1.68e-03351263PF00249
DomainProt_kinase_dom

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 ALK WNK2

1.77e-0348912610IPR000719
DomainPROTEIN_KINASE_DOM

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 ALK WNK2

1.88e-0349312610PS50011
DomainARM-rpt_dom

GPRASP1 GPRASP2

2.39e-03111262IPR006911
DomainArm_2

GPRASP1 GPRASP2

2.39e-03111262PF04826
DomainZF_CXXC

FBXL19 CXXC1

2.39e-03111262PS51058
DomainZnf_CXXC

FBXL19 CXXC1

2.39e-03111262IPR002857
Domainzf-CXXC

FBXL19 CXXC1

2.39e-03111262PF02008
DomainPDZ

MAST2 SHANK2 PDLIM3 TJP1 PDZRN3

2.69e-031411265PF00595
DomainPDZ

MAST2 SHANK2 PDLIM3 TJP1 PDZRN3

3.31e-031481265SM00228
DomainSH3

MIA3 TSPOAP1 PPP1R13L RUSC2 SHANK2 TJP1

3.48e-032161266SM00326
DomainSH3

MIA3 TSPOAP1 PPP1R13L RUSC2 SHANK2 TJP1

3.48e-032161266PS50002
Domain-

MAST2 SHANK2 PDLIM3 TJP1 PDZRN3

3.50e-0315012652.30.42.10
DomainPDZ

MAST2 SHANK2 PDLIM3 TJP1 PDZRN3

3.61e-031511265PS50106
DomainPDZ

MAST2 SHANK2 PDLIM3 TJP1 PDZRN3

3.71e-031521265IPR001478
DomainKinase-like_dom

MARK1 CAMK2G MAP3K14 MAST2 STK35 BUB1 CHEK2 MARK2 ALK WNK2

3.72e-0354212610IPR011009
DomainSH3_domain

MIA3 TSPOAP1 PPP1R13L RUSC2 SHANK2 TJP1

3.81e-032201266IPR001452
DomainTPR_8

SPAG1 CTR9 UTY

5.49e-03531263PF13181
DomainChromodomain_CS

CHD2 CHD3

6.44e-03181262IPR023779
PathwayREACTOME_ALK_MUTANTS_BIND_TKIS

HIP1 BCL11A ALK

5.14e-0512893M42522
PathwayBIOCARTA_PS1_PATHWAY

APC DLL1 AXIN1

8.42e-0514893MM1459
PathwayBIOCARTA_PS1_PATHWAY

APC DLL1 AXIN1

8.42e-0514893M16173
PathwayREACTOME_CHROMATIN_MODIFYING_ENZYMES

BRPF3 ING5 CHD3 KANSL1 NFKB2 KAT6B UTY

1.18e-04175897MM14941
PathwayREACTOME_HATS_ACETYLATE_HISTONES

BRPF3 ING5 KANSL1 KAT6B

1.98e-0446894MM14935
PathwayPID_WNT_CANONICAL_PATHWAY

APC AXIN1 NKD2

2.57e-0420893M90
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FILIP1 FLII GTSE1 TATDN2 DIDO1 TFIP11 CHD3 ZC3H18 MIER1 CIC PACS1 PWWP2B KANSL1 MAP1S USP42 TRIM28 CTR9 FHOD1 MARK2 KAT6B AKAP1 DDX24

2.42e-137741332215302935
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

TBX3 CALD1 RBM26 ING5 DIDO1 CHD3 FBXL19 DLL1 CXXC1 CIC PHF1 JARID2 KLF13 TRIM28 NFKB2 KAT6B UTY ZNF646

2.11e-098081331820412781
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

GPRASP1 FLII MIA3 MAP6 CAMK2G APC DIDO1 BCL11A SPECC1L ARMCX4 ABLIM3 AKAP12 SHANK2 TJP1 TRIM28 BSN CAMSAP1 WNK2 PRRC2B

5.24e-099631331928671696
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

FLII HIP1 KIAA0513 GTSE1 FGFRL1 FBXL19 DLL1 MAST2 CIC CASZ1 EHBP1L1 PWWP2B SHANK2 KANSL1 MAP1S TRIM28 NFKB2 CAMSAP1 WNK2 PRRC2B

8.49e-0911051332035748872
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

TBX3 MIA3 RTN4 APC DIDO1 TFIP11 CHD3 MAST2 RUSC2 PACS1 CTR9 BUB1 TIMM29 MARK2 PRRC2B

3.21e-086501331538777146
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

SAMD1 CALD1 RBM26 APC MAST2 CXXC1 CIC AKAP12 YARS2 PHF1 EHBP1L1 NKD2 USP42 PRRC2B ZNF646

6.86e-086891331536543142
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

CALD1 RTN4 RBM26 DIDO1 TFIP11 CHD3 CIC AKAP12 FAM193A PDLIM3 TJP1 TRIM28 FHOD1 MEPCE CAMSAP1 AKAP1 PRRC2B

1.14e-079341331733916271
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

FLII CALD1 MAP6 MARK1 CAMK2G RTN4 APC CHD3 BCL11A SPECC1L ABLIM3 PACS1 PPP2R2C SHANK2 MAP1S TJP1 TRIM28 MARK2 BSN WNK2 PRRC2B

1.24e-0714311332137142655
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

FLII SUMF2 MIA3 CALD1 APC DIDO1 AKAP12 PACS1 EHBP1L1 TJP1 TRIM28

1.54e-073601331133111431
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

SAMD1 TBX3 ING5 DIDO1 TFIP11 CHD2 CHD3 ZC3H18 MIDEAS CXXC1 MIER1 CIC CASZ1 KANSL1 KLF13 USP42 TRIM28 CTR9 DDX24

5.24e-0712941331930804502
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

FLII CALD1 CAMK2G RTN4 APC SPECC1L AKAP12 POLR3C FAM193A TJP1 LSM14B CAMSAP1 DDX24 PRRC2B

7.93e-077241331436232890
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

TSPOAP1 GTSE1 APOBR CIC FAM193A MAP1S ARHGAP31 BUB1 BSN CAMSAP1 WNK2

8.88e-074301331135044719
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

SAMD1 TBX3 BRPF3 ING5 CHD3 ZC3H18 BCL11A MAST2 PSMG3-AS1 PWWP2B TRIM28 MEPCE KAT6B DDX24 PDZRN3 PRRC2B ZNF646

1.34e-0611161331731753913
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

GPRASP1 MARK1 CAMK2G GTSE1 APC ZC3H18 YARS2 USP42 TJP1 PWP2 MEPCE MARK2 AKAP1 DDX24 GPRASP2 PRRC2B

1.60e-0610051331619615732
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

GPRASP1 FLII MIA3 KIAA0513 MAP6 TSPOAP1 MARK1 CAMK2G RTN4 APC SHANK2 MAP1S TJP1 TRIM28 BSN CAMSAP1 WNK2

1.77e-0611391331736417873
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

SAMD1 CAMK2G RBM26 CIR1 TFIP11 BCL11A PPP1R13L GPR162 CXXC1 AXIN1 RUSC2 NKD2

1.77e-065601331221653829
Pubmed

Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.

BRPF3 ING5 KAT6B

1.89e-067133318794358
Pubmed

A human MAP kinase interactome.

TBX3 ING5 APC SPECC1L MIDEAS CIC KANSL1 ARHGAP31 TRIM28 FHOD1 WNK2

2.89e-064861331120936779
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

BDP1 RNGTT NDE1 APC ZC3H18 CIC POLR3C CTR9 NFKB2 BUB1 BSN PRRC2B

2.92e-065881331238580884
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

DIDO1 SPECC1L CIC RUSC2 KAT6B ZNF646

3.12e-0610413369205841
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

BDP1 CELF5 FLII RTN4 RBM26 TFIP11 CHD2 MAP1S MEPCE MARK2 DDX24

3.58e-064971331136774506
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

SAMD1 HIP1 RNGTT NDE1 RBM26 APC DIDO1 TFIP11 CHD2 SPECC1L CIC CASZ1 JARID2 SHANK2 CTR9 PWP2 MARK2 LSM14B AKAP1

4.45e-0614971331931527615
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

SAMD1 CAMK2G APC CHD3 CIC FAM193A BUB1 CAMSAP1 AKAP1 GPRASP2

5.13e-064181331034709266
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

SAMD1 RBM26 DIDO1 TFIP11 CHD3 ZC3H18 MIDEAS YARS2 KAT6B

7.06e-06341133932971831
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

MIA3 APC AXIN1 FAM193A NKD2 TJP1 CAMSAP1 PRRC2B

8.34e-06263133834702444
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

CALD1 NDE1 APC TFIP11 AKAP12 YARS2 PACS1 KANSL1 MAP1S TJP1 TRIM28 BUB1 CHEK2 MZT2A MARK2 PRRC2B

9.27e-0611551331620360068
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

RBM26 CHD3 MIDEAS CIC CASZ1 CTR9 MEPCE PRRC2B

9.56e-06268133833640491
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

CALD1 MARK1 CAMK2G AFF3 CHD2 AXIN1 MAP1S TRIM28 CTR9 BUB1 PRKAB1 CHEK2 TIMM29 MARK2

1.10e-059101331436736316
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

DIDO1 ZC3H18 PPP1R13L MAST2 MAP1S CHEK2 MYO18B CAMSAP1 PRRC2B

1.11e-05361133926167880
Pubmed

The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.

SAMD1 MARK1 DIDO1 MAP1S CTR9 PWP2 LSM14B DDX24

1.35e-05281133824163370
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

CHD2 CHD3 ZC3H18 EYA1 DNAAF8 PHF1 JARID2 USP42 TRIM28 LSM14B

1.39e-054691331027634302
Pubmed

Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD.

CHD3 TRIM28

1.45e-052133211230151
Pubmed

NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.

MAP3K14 NFKB2

1.45e-052133226045047
Pubmed

TJP1 suppresses trophoblast cell invasion by expressing E2F8 in the human placenta.

E2F8 TJP1

1.45e-052133238795825
Pubmed

Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level.

APC AXIN1

1.45e-052133232005247
Pubmed

Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.

MAP3K14 NFKB2

1.45e-052133222282470
Pubmed

Genetic alterations in members of the Wnt pathway in acute leukemia.

APC AXIN1

1.45e-052133221902576
Pubmed

Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.

KANSL1 KAT6B

1.45e-052133235575789
Pubmed

Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2.

MARK1 MARK2

1.45e-052133216803889
Pubmed

Structural basis of the Axin-adenomatous polyposis coli interaction.

APC AXIN1

1.45e-052133210811618
Pubmed

meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes.

SHANK2 HACE1

1.45e-052133232616021
Pubmed

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

MAP3K14 NFKB2

1.45e-052133211239468
Pubmed

A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.

MAP3K14 NFKB2

1.45e-052133229061763
Pubmed

The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans.

APC CNR2

1.45e-052133236835468
Pubmed

Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway.

MAP3K14 NFKB2

1.45e-052133227416764
Pubmed

NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.

MAP3K14 NFKB2

1.45e-052133224533079
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

MIA3 CAMK2G RTN4 FGFRL1 TFIP11 CHD2 CASZ1 AXIN1 NKD2 USP42 TJP1 TRIM28 FHOD1 MEPCE ABHD16A ZNF646

1.53e-0512031331629180619
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MIA3 APC PPP1R13L AXIN1 FAM193A NFKB2 CAMSAP1

1.68e-05209133736779422
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

CALD1 GTSE1 RBM26 DIDO1 TFIP11 CHD3 ZC3H18 MIDEAS CIC TJP1 TRIM28 PWP2 DDX24 ALK

1.85e-059541331436373674
Pubmed

A High-Density Map for Navigating the Human Polycomb Complexome.

SAMD1 DIDO1 CHD3 BCL11A FBXL19 CXXC1 PHF1 JARID2 KANSL1 TRIM28

2.21e-054951331027705803
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

SAMD1 ING5 DIDO1 CHD2 CHD3 ZC3H18 MIDEAS MIER1 CIC CASZ1 DDX24

2.35e-056081331136089195
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

FLII GTSE1 RBM26 APC DIDO1 PPP1R13L TRIM28 CTR9 MARK2 DDX24

2.53e-055031331016964243
Pubmed

BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.

APC ZC3H18 MAST2 AXIN1 MAP1S TJP1 NFKB2

2.77e-05226133725900982
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

GTSE1 MAP3K14 APC MAST2 CIC E2F8 RUSC2 NKD2 TJP1 MEPCE MARK2 CAMSAP1 AKAP1

2.79e-058611331336931259
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

FLII SUMF2 MARK1 RTN4 GTSE1 ZC3H18 PWP2 MEPCE TIMM29 MARK2 GPRASP2 PRRC2B

3.47e-057541331233060197
Pubmed

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.

ASPHD1 TATDN2 CHD2 CHD3 FBXL19 GPR162 CXXC1 PPP2R2C EHBP1L1 KLF13 PWP2 MEPCE LSM14B AKAP1

3.88e-0510211331426760575
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

APC CIC BUB1 MEPCE MARK2 CAMSAP1 PRRC2B

4.28e-05242133734011540
Pubmed

The NFKB Inducing Kinase Modulates Hematopoiesis During Stress.

MAP3K14 NFKB2

4.34e-053133226037670
Pubmed

Regulation of naive T cell function by the NF-kappaB2 pathway.

MAP3K14 NFKB2

4.34e-053133216732290
Pubmed

Respiratory failure, cleft palate and epilepsy in the mouse model of human Xq22.1 deletion syndrome.

GPRASP1 GPRASP2

4.34e-053133224569167
Pubmed

Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesis.

APC CHEK2

4.34e-053133222159226
Pubmed

RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.

MAP3K14 NFKB2

4.34e-053133218322009
Pubmed

Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity.

MAP3K14 NFKB2

4.34e-053133223301098
Pubmed

Myeloid translocation genes differentially regulate colorectal cancer programs.

APC CBFA2T3

4.34e-053133227270437
Pubmed

Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.

APC BUB1

4.34e-053133217227893
Pubmed

Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.

APC AXIN1

4.34e-053133215981102
Pubmed

different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.

APC AXIN1

4.34e-053133224722208
Pubmed

Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes.

MAP3K14 NFKB2

4.34e-053133217237370
Pubmed

Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma.

APC AXIN1

4.34e-053133216163548
Pubmed

Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A.

APC AXIN1

4.34e-053133211297546
Pubmed

Axin-independent phosphorylation of APC controls beta-catenin signaling via cytoplasmic retention of beta-catenin.

APC AXIN1

4.34e-053133217418091
Pubmed

Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/β-catenin signaling.

APC AXIN1

4.34e-053133229713058
Pubmed

The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.

MAP3K14 NFKB2

4.34e-053133219839765
Pubmed

p100, a precursor of NF-κB2, inhibits c-Rel and reduces the expression of IL-23 in dendritic cells.

MAP3K14 NFKB2

4.34e-053133225305492
Pubmed

CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.

APC AXIN1

4.34e-053133223525311
Pubmed

Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.

APC CNR2

4.34e-053133218676872
Pubmed

KAP-1 phosphorylation regulates CHD3 nucleosome remodeling during the DNA double-strand break response.

CHD3 TRIM28

4.34e-053133221642969
Pubmed

Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer.

APC AXIN1

4.34e-053133231723073
Pubmed

AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin.

APC AXIN1

4.34e-053133227630299
Pubmed

Trim14 promotes osteoclastogenesis and noncanonical NF-κB activation by targeting p100/p52 in chronic periodontitis.

MAP3K14 NFKB2

4.34e-053133233901321
Pubmed

Putative tumor suppressor EDD interacts with and up-regulates APC.

APC AXIN1

4.34e-053133218076571
Pubmed

MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

MARK1 MARK2

4.34e-05313329108484
Pubmed

A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis.

APC AXIN1

4.34e-053133223671587
Pubmed

Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

BDP1 FILIP1 BRPF3 KANSL1 ARHGAP31

4.92e-05103133510574462
Pubmed

p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.

FLII PDLIM3 ALK

5.07e-0519133316105984
Pubmed

SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.

RBM26 TFIP11 ZC3H18 CXXC1 MAP1S TRIM28 CTR9

5.39e-05251133731076518
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

TBX3 CALD1 RTN4 GTSE1 PPP1R13L TJP1 TRIM28 FHOD1 LSM14B

5.60e-05444133934795231
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

MIA3 CALD1 MARK1 APC MAST2 FAM193A MAP1S TJP1 MARK2

5.80e-05446133924255178
Pubmed

Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.

MARK1 TJP1 MARK2

5.94e-0520133318227155
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

CAMK2G RTN4 APC ABLIM3 RUSC2 SHANK2 MARK2 BSN

6.02e-05347133817114649
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

RTN4 GTSE1 RBM26 APC DIDO1 CHD3 TJP1

6.10e-05256133733397691
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

RBM26 DIDO1 CHD2 ZC3H18 YARS2 TRIM28 PWP2 MEPCE LSM14B AKAP1 DDX24 PRRC2B

6.65e-058071331222681889
Pubmed

Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.

CALD1 RTN4 GTSE1 AFF3 DIDO1 CHD2 ZC3H18 NKX2-6 SPECC1L MAST2 NPFFR2 TJP1 FHOD1 HACE1 PRRC2B

6.68e-0512151331515146197
Pubmed

MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.

GTSE1 MAP1S MARK2 CAMSAP1

6.90e-0557133429089450
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

MAP6 MARK1 APC DIDO1 TFIP11 CHD2 ZC3H18 CBFA2T3 CXXC1 EHBP1L1 USP42 TJP1 TRIM28 DDX24

7.22e-0510821331438697112
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

MIA3 MAP6 MARK1 APC DIDO1 TFIP11 CHD2 CHD3 ABLIM3 MIER1 E2F8 AKAP12 PACS1 CTR9

7.37e-0510841331411544199
Pubmed

Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.

FLII SPAG1 MARK1 GTSE1 APC ZC3H18 SPECC1L RUSC2

7.92e-05361133830344098
Pubmed

Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.

CALD1 CAMK2G RTN4 TJP1 UTY

8.66e-05116133530652415
Pubmed

Asymmetric distribution of PAR proteins in the mouse embryo begins at the 8-cell stage during compaction.

TJP1 MARK2

8.67e-054133215950600
Pubmed

The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase.

APC BUB1

8.67e-05413329660858
InteractionSTRN interactions

FILIP1 FLII CALD1 CAMK2G RTN4 APC TFIP11 PPP2R2C MAP1S TJP1

6.15e-0815413010int:STRN
InteractionSOX2 interactions

FLII TBX3 RNGTT MARK1 RTN4 ING5 TFIP11 CHD3 SPECC1L EYA1 PPP1R13L MAST2 ABLIM3 MIDEAS MIER1 CIC TRIM28 CTR9 MEPCE MARK2 LSM14B KAT6B DDX24 PRRC2B

1.22e-05142213024int:SOX2
InteractionBRPF3 interactions

BRPF3 ING5 MAST2 MEPCE KAT6B DDX24 PRRC2B ZNF646

1.24e-051661308int:BRPF3
InteractionSAP30 interactions

BRPF3 CIR1 CHD3 BCL11A MIER1 CIC PHF1 TRIM28

1.30e-051671308int:SAP30
InteractionFXR2 interactions

MIA3 CAMK2G RTN4 GTSE1 MAP3K14 CHD3 ZC3H18 BCL11A AXIN1 NKD2 LSM14B PRRC2B

2.28e-0543013012int:FXR2
InteractionCTTN interactions

CALD1 NDE1 CAMK2G GTSE1 CHD3 SPECC1L RGS14 SHANK2 TJP1 MEPCE OTUD3 ALK

3.55e-0545013012int:CTTN
InteractionRBPJ interactions

FLII SAMD1 CIR1 CHD3 CIC POLR3C TRIM28 CAMSAP1 DDX24

4.07e-052541309int:RBPJ
InteractionTRIM36 interactions

GTSE1 APC SPECC1L EHBP1L1 MAP1S MARK2 CAMSAP1

4.17e-051441307int:TRIM36
InteractionMSI1 interactions

CELF5 ZC3H18 YARS2 ARHGAP31 MEPCE AKAP1

7.17e-051081306int:MSI1
InteractionKCTD13 interactions

GPRASP1 FLII CALD1 MAP6 MARK1 CAMK2G RTN4 APC CHD3 BCL11A SPECC1L ABLIM3 PACS1 PPP2R2C SHANK2 MAP1S TJP1 TRIM28 MARK2 BSN WNK2 PRRC2B

8.08e-05139413022int:KCTD13
InteractionRCOR1 interactions

FLII SAMD1 APC CHD3 MIER1 CIC FAM193A TRIM28 BUB1 CAMSAP1 AKAP1 GPRASP2

8.66e-0549413012int:RCOR1
InteractionHDAC1 interactions

FLII TBX3 CAMK2G APC CHD3 BCL11A CBFA2T3 MIDEAS MIER1 CIC CASZ1 PHF1 PWWP2B KLF13 TRIM28 BUB1 CAMSAP1 AKAP1 GPRASP2

8.98e-05110813019int:HDAC1
InteractionNAV3 interactions

ING5 APC SPECC1L EHBP1L1

1.03e-04381304int:NAV3
InteractionYWHAZ interactions

BDP1 NDE1 MAP6 MARK1 CAMK2G RBM26 APC ZC3H18 MAST2 CIC E2F8 RUSC2 PACS1 NKD2 TJP1 FHOD1 MEPCE MARK2 CAMSAP1 DDX24 WNK2

1.06e-04131913021int:YWHAZ
InteractionDISC1 interactions

FLII CALD1 NDE1 TSPOAP1 TFIP11 SPECC1L POLR3C PHF1 KANSL1 MEPCE GPRASP2

1.07e-0442913011int:DISC1
Cytoband22q12.1

TFIP11 CHEK2 MYO18B

1.11e-0432133322q12.1
CytobandXq22.1

GPRASP1 ARMCX4 GPRASP2

2.69e-04431333Xq22.1
GeneFamilyPHD finger proteins

BRPF3 ING5 DIDO1 CHD3 FBXL19 CXXC1 PHF1 TRIM28 KAT6B

5.16e-109088988
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

GPRASP1 APC ARMCX4 GPRASP2

5.59e-0543884409
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

BDP1 MIDEAS MIER1 ZNF541

1.28e-0453884532
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

RBM26 APC AXIN1 TRIM28 PCIF1 AKAP1

2.54e-04181886694
GeneFamilyZinc fingers MYND-type|A-kinase anchoring proteins

CBFA2T3 AKAP12 AKAP1

3.71e-0429883396
GeneFamilyPDZ domain containing

MAST2 SHANK2 PDLIM3 TJP1 PDZRN3

8.79e-041528851220
GeneFamilyZinc fingers CXXC-type

FBXL19 CXXC1

1.50e-0312882136
GeneFamilyZinc fingers MYND-type

ZMYND15 CBFA2T3

4.63e-032188287
GeneFamilyPWWP domain containing

BRPF3 PWWP2B

5.08e-03228821147
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

BDP1 CELF5 GPRASP1 MIA3 JPH4 MAP6 TSPOAP1 MARK1 RTN4 AFF3 RBM26 APC TATDN2 CHD3 BCL11A ABLIM3 CASZ1 RUSC2 PACS1 PPP2R2C SHANK2 SMPD3 BSN PRRC2B

1.18e-09110613124M39071
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HNBML5

CELF5 JPH4 MAP6 TSPOAP1 MARK1 APC BCL11A EYA1 ABLIM3 CASZ1 SHANK2 SMPD3 BSN AKAP1

9.31e-0846513114M39066
CoexpressionNAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN

GPRASP1 BRPF3 NDE1 RTN4 RBM26 CIR1 TFIP11 CHD2 STK35 MIER1 PHF1 JARID2 USP42 PCIF1 DDX24

1.65e-0668013115M41089
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HNBGABA

BDP1 CELF5 GPRASP1 JPH4 MAP6 MARK1 ABLIM3 CASZ1 SORCS1 PPP2R2C SHANK2 SMPD3 BSN AKAP1

1.19e-0570313114M39070
CoexpressionHEVNER_INTERMEDIATE_ZONE_AND_UP_POSTMITOTIC_NEURONS

KIAA0513 APC CHD3 BCL11A WNK2

1.74e-05641315MM408
CoexpressionGRESHOCK_CANCER_COPY_NUMBER_UP

HIP1 AFF3 APC BCL11A CBFA2T3 NFKB2 CHEK2 KAT6B ALK

3.72e-053231319M9150
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HDA1

CELF5 GPRASP1 JPH4 MAP6 TSPOAP1 MARK1 CHD3 BCL11A MAST2 ABLIM3 SHANK2 SMPD3

3.82e-0558413112M39068
CoexpressionTHAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN

ZMYND15 LST1 FLII NDE1 DIDO1 DLL1 MIDEAS GPR162 APOBR CXXC1 CASZ1 AXIN1 JARID2 EHBP1L1 KLF13

4.84e-0590513115M40865
CoexpressionGSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP

CHD2 STK35 DNAAF8 PHF1 JARID2 USP42 DDX24

6.00e-051961317M4928
CoexpressionGSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN

MIA3 CHD3 ZC3H18 PHF1 PACS1 ARHGAP31 PRRC2B

6.60e-051991317M9443
CoexpressionGSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP

TFIP11 CIC AXIN1 PWP2 MEPCE MARK2 CAMSAP1

6.60e-051991317M9038
CoexpressionIWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN

HIP1 CIR1 CBFA2T3 MIDEAS TTLL8 AKAP12 PDLIM3 OTUD3 CNR2

9.11e-053631319M6315
CoexpressionKRIEG_HYPOXIA_NOT_VIA_KDM3A

SPAG1 KIAA0513 FGFRL1 PPP1R13L CIC AKAP12 AXIN1 PACS1 EHBP1L1 SHANK2 KLF13 BUB1 PCIF1

9.65e-0574613113M2469
CoexpressionIWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN

HIP1 CIR1 CBFA2T3 MIDEAS TTLL8 AKAP12 PDLIM3 OTUD3 CNR2

1.10e-043721319MM1043
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 CALD1 CAMK2G AFF3 EHBP1L1 PDLIM3 MYO18B WNK2

1.05e-071891338127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 CALD1 CAMK2G AFF3 EHBP1L1 PDLIM3 MYO18B WNK2

1.05e-0718913382cfb4d12f75678d1619f4743838a0e954bd57761
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBX3 HIP1 KIAA0513 ARMCX4 CASZ1 PTPRG ARHGAP31 TJP1

1.28e-0719413381b382508453c5b08fb617f626b230adf3b6cff99
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBX3 HIP1 KIAA0513 ARMCX4 CASZ1 PTPRG ARHGAP31 TJP1

1.33e-071951338cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

AFF3 BCL11A CBFA2T3 APOBR EHBP1L1 SMPD3 CNR2

9.11e-07173133773f858f2c45d19b9ec8d99ac02c91551790f670c
ToppCelldroplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 TBX3 HIP1 CALD1 ARMCX4 DLL1 PWWP2B

1.02e-061761337c4d9166e5bbb7ca544107db14e4374289f5de6bd
ToppCelldroplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 TBX3 HIP1 CALD1 ARMCX4 DLL1 PWWP2B

1.02e-061761337d58ef51002ea50b3037636038214bbb7454cb503
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

FILIP1 CALD1 AFF3 CASZ1 PDLIM3 MYO18B WNK2

1.59e-0618813376d249fe92d51a19da19ec14bb2262d394255d577
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 HIP1 CALD1 AFF3 PDLIM3 MYO18B WNK2

1.83e-061921337bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 HIP1 CALD1 AFF3 PDLIM3 MYO18B WNK2

1.83e-061921337b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCellCOPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

FILIP1 CALD1 AKAP12 PDLIM3 NKD2 PTPRG PDZRN3

2.17e-061971337d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCellNeuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster

CELF5 JPH4 MAP6 RTN4 AFF3 CHD3 BCL11A

2.32e-061991337058373b4ac3cec2108cb24265628ff0a50646e33
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type.

CELF5 MAP6 ABLIM3 SHANK2 SMPD3 WNK2 PRRC2B

2.39e-062001337c92e4fc0442404481fcac623d691dae6215b852d
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type.

CELF5 JPH4 MAP6 AFF3 BCL11A SHANK2 SMPD3

2.39e-0620013375b3df61ff421846ef4cabf1bd5355534c8b95509
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TBX3 CALD1 MARK1 PDLIM3 PTPRG PDZRN3

6.49e-061521336621e9b33cd3bb1c7b7d0633069f286b203e3d9c0
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

TBX3 CALD1 MARK1 PTPRG ATOH8 PDZRN3

6.73e-0615313361524557514668f515ac1bbe847611f564b265b42
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

GPRASP1 TBX3 CALD1 MARK1 PDLIM3 PTPRG

7.25e-061551336cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCelllymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass

TBX3 TSPOAP1 MIDEAS CASZ1 AKAP12 SORCS1

8.70e-06160133666fe86d2f37983761141e5bb3de127f0b4bb0951
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9

AFF3 SLC9A2 SHANK2 ATOH8 INSM2 SMPD3

9.01e-0616113365f6b2d7f80a8ee16651e304481d2da3fae313824
ToppCellmetastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass

ZMYND15 AFF3 BCL11A CBFA2T3 SMPD3 UTY

1.00e-05164133606db4cc064f0765c481ce880207823872c27bfa9
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

GPRASP1 TBX3 CALD1 MARK1 PTPRG PDZRN3

1.07e-05166133694636dbc039f794c735960c3425e00bdd5523602
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LST1 CBFA2T3 DNAAF8 SCARF1 NFKB2 CNR2

1.19e-0516913364de0c60f3c163b7823f739ebda4e0afc68346628
ToppCell10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue

LST1 AFF3 DLL1 SORCS1 SCARF1 MYO18B

1.23e-05170133697df5ffb328196c46568975d2d97722bcc753bf5
ToppCell356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells)

TBX3 CALD1 MARK1 PDLIM3 NKD2 BSN

1.36e-05173133675e26a65071b0d2f30ed0b2aa9859c488f5cf362
ToppCell356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells)

TBX3 CALD1 MARK1 PDLIM3 NKD2 BSN

1.36e-05173133626e2e674f5d312fa8f61c11b553dc6101f063b16
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CHD2 CASZ1 SLC9A2 SHANK2 INSM2 WNK2

1.50e-0517613363bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CALD1 MAP6 SORCS1 PPP2R2C NKD2 XKR5

1.70e-051801336f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCellControl-T/NK_proliferative|Control / Disease group and Cell class

GTSE1 SPECC1L E2F8 TRBV7-4 BUB1 CHEK2

1.86e-05183133609c2b4e630f1c338f02c1242e3598e870d6b0a28
ToppCellmoderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TBX3 ASPHD1 CALD1 AKAP12 SORCS1 PDLIM3

1.98e-0518513364979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCellwk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

KIAA0513 TSPOAP1 FBXL19 PWWP2B MEPCE WNK2

1.98e-051851336636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCellChildren_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TBX3 CALD1 CBFA2T3 PTPRG TJP1 WNK2

2.11e-05187133686250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

FILIP1 BCL11A CASZ1 MYO18B PDZRN3 WNK2

2.24e-0518913365e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellmoderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TBX3 ASPHD1 CALD1 AKAP12 SORCS1 PDLIM3

2.24e-05189133622a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

FILIP1 EYA1 MAST2 PDLIM3 MYO18B PDZRN3

2.24e-0518913360a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

FILIP1 CALD1 EYA1 MAST2 PDLIM3 MYO18B

2.30e-05190133693c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue

GTSE1 AFF3 BCL11A CBFA2T3 E2F8 BUB1

2.37e-051911336aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9
ToppCellLA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper

FILIP1 CALD1 CASZ1 PDLIM3 MYO18B WNK2

2.37e-0519113365d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

AFF3 BCL11A CBFA2T3 PWWP2B NFKB2 CNR2

2.37e-051911336b7d17d3ba488378b30f3732f8109f4a7c1673e61
ToppCell11.5-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class

CELF5 JPH4 ASPHD1 SORCS1 PPP2R2C ALK

2.44e-051921336a77d3692ff02ef7e066a9bd9e22725055a25c4d4
ToppCellPND10-Endothelial-Endothelial_blood-vessel|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBX3 HIP1 CASZ1 PTPRG ARHGAP31 TJP1

2.52e-0519313361d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486
ToppCellT_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

LST1 HIP1 AFF3 BCL11A DLL1 CNR2

2.52e-051931336826457e2aafdb61ead8a0a44d8cf9088d310684b
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBX3 HIP1 CASZ1 PTPRG ARHGAP31 TJP1

2.52e-051931336097a244cf37ce6c1ace9bae56beb7de59442cd6b
ToppCellPND10-Endothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBX3 HIP1 CASZ1 PTPRG ARHGAP31 TJP1

2.52e-051931336f3c743b340fc588bc8effd375b12e2c7cbfa49d2
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FILIP1 CALD1 CAMK2G BCL11A AKAP12 PDLIM3

2.59e-05194133693bc72a933ccc6a760e5353f072afb606571c6fc
ToppCellControl-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

CALD1 AKAP12 PDLIM3 NKD2 PTPRG PDZRN3

2.59e-0519413363c2266772c5b56e8e02a461e5193e29588028ee9
ToppCelldroplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 TBX3 CALD1 MARK1 PDLIM3 ATOH8

2.59e-05194133680be44e9ddd9f6ddd9dff7cba0eb457431204c2d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 CALD1 AFF3 AKAP12 PDLIM3 NFKB2

2.59e-05194133690efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 CALD1 AFF3 AKAP12 PDLIM3 NFKB2

2.59e-051941336df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 CALD1 AFF3 PDLIM3 MYO18B WNK2

2.59e-0519413365c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

FILIP1 CALD1 CASZ1 MYO18B PDZRN3 WNK2

2.59e-051941336c3535f7cc0076653c72db582047cff053c322397
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 CALD1 AFF3 PDLIM3 MYO18B WNK2

2.59e-051941336ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCelldroplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TBX3 DLL1 CASZ1 AKAP12 PTPRG TJP1

2.59e-051941336fc3f81b5bdc544a69c355e482f002643e029a7b0
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 TBX3 CALD1 MARK1 PDLIM3 WNK2

2.59e-051941336b8a130ffae68ffe550bf335460a1ec1035cf8d8d
ToppCellCOVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type

FILIP1 CASZ1 PDLIM3 MYO18B PDZRN3 WNK2

2.67e-051951336f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

FILIP1 CASZ1 PDLIM3 MYO18B PDZRN3 WNK2

2.67e-05195133675fc81bddb246dca3b437fb60827b1d4fe416405
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 TBX3 CALD1 MARK1 PDLIM3 WNK2

2.67e-0519513360bdf845939bc4b8cc94f2808aea60f818425b076
ToppCellCOPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class

FILIP1 CALD1 PDLIM3 NKD2 PTPRG PDZRN3

2.74e-051961336af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCellBronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ZMYND15 GTSE1 BCL11A CBFA2T3 SCARF1 BUB1

2.74e-05196133653d1f9e9f009d1417a19ca6f9a83ecdf7776ef88
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

CALD1 AKAP12 PDLIM3 NKD2 PTPRG PDZRN3

2.74e-051961336bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell5'-Airway_Nasal-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LST1 BCL11A CBFA2T3 APOBR EHBP1L1 SMPD3

2.74e-0519613369c942bf9fc78caa173d2c7de5fe4c17f076c623b
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FILIP1 TBX3 CALD1 AKAP12 NKD2 PDZRN3

2.82e-0519713360dd71e399f253787fa546a7e90c5373180b89ffd
ToppCellMonocytes-cDCs|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis

HIP1 AFF3 BCL11A CBFA2T3 MAGEF1 AKAP1

2.82e-05197133615cb9fe1c3bab80bd24728fd9ac7ba385912ac33
ToppCellCOPD-Stromal|COPD / Disease state, Lineage and Cell class

CALD1 AKAP12 PDLIM3 NKD2 PTPRG PDZRN3

2.82e-051971336d5390d86acaa8c39f1da893e8d2271f9ed2951d7
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CALD1 MARK1 AKAP12 EHBP1L1 PDLIM3 PDZRN3

2.90e-051981336bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FILIP1 EYA1 PPP1R13L SHANK2 ATOH8 FHOD1

2.90e-051981336b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellFetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CALD1 ABLIM3 AKAP12 PDLIM3 PTPRG PDZRN3

2.90e-05198133621cf4d81386761d09d0f6829c01c198e5524176d
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

CALD1 ABLIM3 AKAP12 PDLIM3 PTPRG PDZRN3

2.99e-0519913364bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LST1 EHBP1L1 MAP1S NFKB2 MEPCE MARK2

2.99e-051991336bbb4798d6a24e756fea744a151ba67c1bafbac9a
ToppCellNeuron|World / Primary Cells by Cluster

CELF5 JPH4 MAP6 RTN4 AFF3 BCL11A

2.99e-0519913361f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCellNeuron-Postmitotic|World / Primary Cells by Cluster

CELF5 JPH4 MAP6 RTN4 AFF3 BCL11A

2.99e-0519913361973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CALD1 MARK1 AKAP12 EHBP1L1 PDLIM3 PDZRN3

2.99e-051991336b1753474152b82a0b811b9878c890a359e14919a
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CALD1 ABLIM3 AKAP12 PDLIM3 NKD2 PDZRN3

3.07e-052001336e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type.

CELF5 JPH4 BCL11A SHANK2 SMPD3 PDZRN3

3.07e-052001336306926cb7a847871641f02e03d52dc56fd55711c
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type.

FILIP1 ABLIM3 CASZ1 EHBP1L1 PDLIM3 MYO18B

3.07e-052001336538ae964db58c4acafe93f735b3e03fc08fdaac6
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type.

FILIP1 ABLIM3 E2F8 EHBP1L1 PDLIM3 MYO18B

3.07e-0520013360f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCellBrain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type.

CELF5 JPH4 CHD3 BCL11A KAT6B PRRC2B

3.07e-0520013362a635694844ddabcd98462c5636a6f41a3f08a46
ToppCellprimary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NDE1 GTSE1 E2F8 BUB1 CHEK2

4.29e-051291335ff74d159034a09f7b174da18bfb9a26936252b4c
ToppCellSevere-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

HIP1 RNGTT AFF3 CHD3 DLL1

7.49e-051451335a24cad86509208bc7267b02ef1d1b0a25a2a7043
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D175|Adult / Lineage, Cell type, age group and donor

SPECC1L CIC PTPRG OTUD3 SMPD3

8.25e-051481335012845b10850bbc67814da247ee5a69f6d631eaa
ToppCellfacs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 MAP3K14 E2F8 JARID2 OTUD3

9.64e-0515313358cc2667213bfac37545bb63181e88ef1f1834413
ToppCellfacs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 MAP3K14 E2F8 JARID2 OTUD3

9.64e-051531335596bb7cfd1c713708ce73df30d890a0233eae7f7
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

CALD1 CAMK2G CASZ1 PDLIM3 AKAP1

9.64e-051531335ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCell10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue

SPAG1 DLL1 SORCS1 MYO18B ZNF646

1.03e-04155133583430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

CALD1 MARK1 PPP2R2C PDLIM3 PDZRN3

1.12e-04158133584c0a215dabf697ada036c2b9592d0c61b5077de
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GPR84 MIDEAS USP42 NFKB2 MEPCE

1.16e-0415913352f6c60ddff2208a68146f9786143d9aefd528840
ToppCellBronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

ASPHD1 ABLIM3 APOBR NPFFR2 SLC9A2

1.16e-04159133595834b767cfb4fb8c5aeea89c10f3e14a1fd15c1
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GPR84 MIDEAS USP42 NFKB2 MEPCE

1.16e-041591335ded4e3626a62fb6334403b7213b467fb7e8131c3
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

CALD1 MARK1 AKAP12 PDLIM3 PDZRN3

1.23e-04161133564891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

HIP1 CALD1 NDE1 AKAP12 PDLIM3

1.23e-04161133547b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FILIP1 CALD1 CASZ1 AKAP12 PDLIM3

1.30e-041631335e526104a3a574ee860078ce7c049e7fec9443f37
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AFF3 BCL11A CBFA2T3 SMPD3 CNR2

1.37e-041651335e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf
ToppCellfacs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 FLII SAMD1 E2F8 CHEK2

1.41e-0416613355c132f505dc5f699c87913f140344fc9f8e7e0f5
ToppCellCOPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class

LST1 HIP1 AFF3 DLL1 ARHGAP31

1.41e-041661335e2cad1db536d5ad5a34c337c19b5e7d1a2851552
ToppCellnormal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

CBFA2T3 SCARF1 MZT2A SMPD3 CNR2

1.41e-0416613356210a136efb99d70c2026b6454363f1bd2723558
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TSPOAP1 BCL11A CBFA2T3 PWP2 SMPD3

1.41e-041661335c8a7d94ed762e5e045ab5f74eef691ddc5f74993
ToppCell10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue

LST1 AFF3 DLL1 SORCS1 SCARF1

1.49e-041681335d02eba7ece17edcdd47fd6b784c93910ce61090f
ToppCellmetastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

AFF3 BCL11A RELL2 SMPD3 UTY

1.49e-0416813354bf3f85aac4b335efa93d22c9ce7b153cb5ce152
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBX3 BCL11A SPECC1L CASZ1 KANSL1

1.54e-0416913354e1322cc5e1733e9fb19e08f739a30206f43cea8
ToppCelldroplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PPP1R13L GPR162 E2F8 RELL2 BUB1

1.58e-041701335badbe200e9d5003d23d115955b10b4ea767f6c26
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related|GW09 / Sample Type, Dataset, Time_group, and Cell type.

RBM26 CIR1 DLL1 PRRC2B

1.60e-0491133425197fde8b9bdaf1e28add695d13aff3ff52d86e
ComputationalNeighborhood of BCL2L1

BRPF3 RTN4 MEPCE PRRC2B

9.22e-0535744GCM_BCL2L1
DrugNaftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A

HIP1 CAMK2G MAP3K14 DIDO1 MAST2 RUSC2 EHBP1L1 MAP1S NFKB2 PCIF1 KAT6B

1.73e-08196130112974_DN
DrugMetyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A

FLII CALD1 KIAA0513 CAMK2G TFIP11 BCL11A MAST2 RUSC2 NFKB2 PRRC2B

2.03e-07197130104606_DN
DrugAnisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A

NDE1 CAMK2G GTSE1 BCL11A CXXC1 AXIN1 EHBP1L1 CAMSAP1 AKAP1

1.31e-0618713096764_DN
DrugMegestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A

APC TFIP11 BCL11A CASZ1 RUSC2 PACS1 SLC9A2 MAP1S LSM14B

1.78e-0619413096667_DN
Drugrottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA

RNGTT ASPHD1 TFIP11 PPP1R13L AKAP12 SHANK2 CAMSAP1 KAT6B PRRC2B

2.02e-061971309825_DN
DrugMebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A

CALD1 KIAA0513 APC BCL11A MAGEF1 EHBP1L1 MAP1S CHEK2 UTY

2.11e-0619813097370_DN
DrugTrimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A

GPRASP1 FLII HIP1 ASPHD1 DIDO1 MAST2 AKAP12 EHBP1L1 PCIF1

2.20e-0619913092802_DN
DrugMefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A

APC CIR1 DIDO1 TFIP11 CHD3 CIC PCIF1 AKAP1 CNR2

2.20e-0619913095534_DN
DrugAnisomycin [22862-76-6]; Down 200; 15uM; HL60; HT_HG-U133A

BCL11A SPECC1L APOBR E2F8 FHOD1 CAMSAP1 AKAP1 PRRC2B

1.05e-0518313081304_DN
DrugPyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A

ASPHD1 GTSE1 CXXC1 E2F8 AKAP12 KAT6B AKAP1 UTY

1.19e-0518613083518_DN
Drug15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A

GTSE1 CBFA2T3 PPP1R13L E2F8 AXIN1 BUB1 KAT6B AKAP1

1.23e-0518713086948_DN
DrugMebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A

NDE1 BCL11A MAST2 RUSC2 PACS1 SHANK2 MAP1S KLF13

1.55e-0519313087147_UP
DrugHymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A

GPRASP1 CALD1 APC BCL11A MAGEF1 RUSC2 BUB1 CNR2

1.55e-0519313084623_DN
DrugPrazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A

GPRASP1 NDE1 MAP3K14 CHD3 MAGEF1 PCIF1 UTY PRRC2B

1.55e-0519313083098_DN
DrugTetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A

CALD1 RBM26 CHD3 CXXC1 CIC PACS1 EHBP1L1 OTUD3

1.61e-0519413086769_UP
DrugMometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A

DIDO1 BCL11A MAST2 APOBR CIC NFKB2 PWP2 KAT6B

1.80e-0519713081746_DN
DrugFlunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A

GPRASP1 RNGTT PPP1R13L CIC AXIN1 SLC9A2 FHOD1 PRRC2B

1.80e-0519713083411_DN
DrugBretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A

RNGTT APC TFIP11 MAST2 PACS1 SHANK2 PCIF1 ALK

1.93e-0519913086674_DN
DrugRifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A

DIDO1 CBFA2T3 AXIN1 SLC9A2 PCIF1 MEPCE KAT6B

9.19e-0518413074349_DN
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

NDE1 CXXC1 E2F8 JARID2 BUB1 KAT6B AKAP1

1.05e-0418813076451_DN
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CAMK2G E2F8 JARID2 BUB1 PCIF1 KAT6B AKAP1

1.09e-0418913075248_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A

HIP1 CALD1 GTSE1 APC MAST2 LSM14B UTY

1.09e-0418913075084_DN
DrugGramine [87-52-5]; Up 200; 23uM; HL60; HT_HG-U133A

GPRASP1 NDE1 AFF3 BUB1 LSM14B CAMSAP1 CNR2

1.12e-0419013072143_UP
DrugBiCl3

GPR162 BSN ALK

1.17e-04171303CID000024591
DrugRapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A

GPRASP1 DIDO1 BCL11A AKAP12 RGS14 BUB1 PCIF1

1.20e-0419213071221_UP
DrugSuloctidil [54063-56-8]; Down 200; 11.8uM; HL60; HT_HG-U133A

FLII NDE1 CBFA2T3 MAGEF1 PRKAB1 CAMSAP1 AKAP1

1.24e-0419313071297_DN
DrugCefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A

BCL11A RGS14 SLC9A2 KLF13 NFKB2 BUB1 LSM14B

1.24e-0419313074067_DN
DrugTrichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A

CALD1 KIAA0513 EYA1 GPR162 AXIN1 SHANK2 ZNF646

1.28e-0419413072998_UP
DrugResveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A

RNGTT RTN4 GTSE1 DIDO1 BCL11A CIC PRRC2B

1.28e-0419413071715_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

ASPHD1 GTSE1 APC CIR1 CIC MAP1S UTY

1.28e-0419413073828_DN
DrugCephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A

APC AXIN1 PHF1 RGS14 SLC9A2 KLF13 PCIF1

1.28e-0419413074242_DN
DrugMetaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A

APC TFIP11 BCL11A RGS14 BUB1 AKAP1 ALK

1.32e-0419513073669_DN
DrugTolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A

KIAA0513 NDE1 CAMK2G CIR1 CIC RGS14 UTY

1.32e-0419513071501_DN
DrugFusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A

NDE1 TSPOAP1 MAST2 CIC FHOD1 PCIF1 MARK2

1.32e-0419513071293_DN
DrugUrsolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A

NDE1 CIR1 EHBP1L1 MAP1S FHOD1 CAMSAP1 UTY

1.32e-0419513075825_DN
DrugPrenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A

KIAA0513 CAMK2G E2F8 RGS14 EHBP1L1 SHANK2 FHOD1

1.32e-0419513075070_DN
DrugNabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A

GPRASP1 MIA3 MAST2 RUSC2 MARK2 LSM14B UTY

1.32e-0419513075428_DN
DrugDebrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A

ASPHD1 NDE1 CIC PACS1 MARK2 KAT6B PRRC2B

1.36e-0419613075288_UP
Drugalpha-estradiol; Up 200; 0.01uM; ssMCF7; HG-U133A

CALD1 MAP3K14 CHD2 EYA1 MAST2 ABLIM3 UTY

1.36e-041961307403_UP
DrugPentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A

HIP1 CAMK2G APC DIDO1 MAST2 AXIN1 PCIF1

1.36e-0419613072473_DN
Drug2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A

HIP1 ASPHD1 NDE1 CIR1 CASZ1 PACS1 EHBP1L1

1.36e-0419613071639_UP
DrugCromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; PC3; HT_HG-U133A

HIP1 RNGTT CALD1 AXIN1 RGS14 LSM14B UTY

1.36e-0419613075754_DN
DrugCefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A

CALD1 APC ABLIM3 RUSC2 EHBP1L1 MAP1S UTY

1.36e-0419613074718_DN
DrugIsosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A

GPRASP1 NDE1 APC RUSC2 PCIF1 DMP1 LSM14B

1.36e-0419613072183_DN
DrugSolanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A

TBX3 RNGTT ASPHD1 MAST2 CIC EHBP1L1 PCIF1

1.36e-0419613074166_DN
DrugProbucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A

MIA3 MAP3K14 MAST2 AXIN1 MAP1S MARK2 CAMSAP1

1.36e-0419613075261_DN
DrugEconazole nitrate [24169-02-6]; Down 200; 9uM; HL60; HT_HG-U133A

TSPOAP1 TFIP11 CIC RGS14 OTUD3 KAT6B ALK

1.36e-0419613072396_DN
DrugClioquinol [130-26-7]; Down 200; 13uM; PC3; HT_HG-U133A

RNGTT RBM26 DIDO1 TFIP11 AXIN1 RGS14 KLF13

1.36e-0419613074663_DN
DrugNaphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A

TBX3 HIP1 MIA3 RNGTT PACS1 BUB1 MARK2

1.41e-0419713074949_UP
DrugSulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HG-U133A

CALD1 CHD3 AXIN1 YARS2 RUSC2 LSM14B PRRC2B

1.41e-0419713071887_UP
DrugDiloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A

MIA3 RNGTT CALD1 TFIP11 PACS1 SLC9A2 PRRC2B

1.41e-0419713075025_DN
DrugICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A

CALD1 TSPOAP1 RUSC2 PHF1 EHBP1L1 ALK ZNF646

1.41e-0419713075202_UP
Drugchlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A

NDE1 MARK1 MAST2 ABLIM3 AKAP12 RUSC2 LSM14B

1.41e-0419713076936_UP
Drugresveratrol; Down 200; 50uM; PC3; HG-U133A

TBX3 GTSE1 MAST2 AXIN1 PWP2 OTUD3 CAMSAP1

1.41e-041971307662_DN
DrugIoversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A

ASPHD1 APC PTPRG MARK2 DMP1 AKAP1 CNR2

1.41e-0419713076726_UP
DrugMeclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A

CALD1 NDE1 APC AXIN1 RUSC2 PHF1 NFKB2

1.41e-0419713074729_UP
Drug2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A

NDE1 APC DIDO1 AXIN1 PACS1 PCIF1 MARK2

1.41e-0419713076974_DN
DrugAltretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A

RNGTT MAST2 CIC AXIN1 SLC9A2 NFKB2 MARK2

1.45e-0419813075688_DN
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MIA3 NDE1 DIDO1 AKAP12 PACS1 RGS14 UTY

1.45e-0419813074367_DN
DrugHyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A

CALD1 BCL11A GPR162 PHF1 LSM14B ALK CNR2

1.45e-0419813072108_UP
DrugGlafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A

KIAA0513 NDE1 CHD3 MAST2 AKAP12 MAP1S PRRC2B

1.45e-0419813077018_UP
DrugBufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A

APC DIDO1 SLC9A2 BUB1 PCIF1 LSM14B AKAP1

1.45e-0419813075515_DN
DrugEthamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A

RNGTT CIR1 AXIN1 RUSC2 RGS14 SHANK2 LSM14B

1.45e-0419813074576_DN
DrugUngerine nitrate; Down 200; 10.2uM; PC3; HT_HG-U133A

RNGTT CALD1 MAP3K14 MAST2 MAGEF1 MAP1S FHOD1

1.45e-0419813075816_DN
DrugMethotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A

GPRASP1 RNGTT NDE1 APC BUB1 UTY PRRC2B

1.45e-0419813077399_DN
DrugPalmatine chloride [3486-67-7]; Up 200; 10.4uM; HL60; HT_HG-U133A

NDE1 CASZ1 RUSC2 TJP1 NFKB2 CAMSAP1 ALK

1.45e-0419813072138_UP
Drugiloprost; Up 200; 1uM; SKMEL5; HG-U133A

MAP3K14 BCL11A EYA1 BUB1 PWP2 KAT6B ALK

1.50e-041991307496_UP
DrugNicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A

NDE1 GTSE1 APC CXXC1 AXIN1 EHBP1L1 MARK2

1.50e-0419913072220_DN
DrugPyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A

CAMK2G MAP3K14 APC MAST2 CASZ1 OTUD3 PRRC2B

1.50e-0419913075513_DN
DrugFolinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A

GPRASP1 KIAA0513 NDE1 CHD3 BCL11A SHANK2 FHOD1

1.50e-0419913077401_DN
Drugikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA

RNGTT ASPHD1 CIR1 TFIP11 MARK2 KAT6B PDZRN3

1.50e-041991307918_DN
Drug2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A

GPRASP1 APC CHD3 SPECC1L MAGEF1 RUSC2 PACS1

1.50e-0419913076321_DN
DrugChlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A

HIP1 CALD1 CAMK2G MAST2 CIC RUSC2 EHBP1L1

1.54e-0420013075391_UP
Drug2-(2,6-dimethylmorpholin-4-yl)-N-(5-(6-morpholin-4-yl-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide

TRIM28 CHEK2

1.93e-0441302ctd:C546193
DiseaseIntellectual Disability

AFF3 APC CHD3 BCL11A SPECC1L DLL1 CIC PACS1 SHANK2 KANSL1

2.02e-0544712410C3714756
DiseaseApraxia of Phonation

CHD3 BCL11A

5.24e-0531242C0264611
Diseasevisual impairment and progressive phthisis bulbi (implicated_via_orthology)

MARK1 MARK2

1.05e-0441242DOID:0070356 (implicated_via_orthology)
Diseasereticulocyte measurement

AFF3 FGFRL1 BCL11A EYA1 CBFA2T3 MIDEAS SCARF1 PACS1 KANSL1 KLF13 USP42 PCIF1 CHEK2 BSN

1.42e-04105312414EFO_0010700
Diseasearrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology)

PPP1R13L PDLIM3

1.74e-0451242DOID:0050431 (implicated_via_orthology)
DiseaseHereditary Diffuse Gastric Cancer

FILIP1 TBX3 MARK1 APC PTPRG PRKAB1 CHEK2

2.48e-042931247C1708349
DiseaseHepatoblastoma

APC AXIN1

2.60e-0461242C0206624
DiseaseStomach Neoplasms

FILIP1 TBX3 MARK1 APC PTPRG PRKAB1 CHEK2

2.69e-042971247C0038356
DiseaseMalignant neoplasm of stomach

FILIP1 TBX3 MARK1 APC PTPRG PRKAB1 CHEK2

2.86e-043001247C0024623
DiseaseNeural crest tumor

HACE1 ALK

3.63e-0471242C2931189
Diseasetumor necrosis factor receptor II measurement

LST1 RGS14

4.82e-0481242EFO_0008384
DiseaseMalignant neoplasm of breast

TBX3 BCL11A DLL1 CIC AKAP12 SORCS1 SLC9A2 CHEK2 KAT6B ALK CNR2 ZNF541 ZNF646

6.01e-04107412413C0006142
DiseaseHEPATOCELLULAR CARCINOMA

APC AXIN1

6.19e-0491242114550
DiseaseHepatocellular carcinoma

APC AXIN1

6.19e-0491242cv:C2239176
DiseaseNeuroblastoma

HACE1 CHEK2 ALK

1.03e-03471243C0027819
Diseaseintelligence, self reported educational attainment

AFF3 BCL11A FAM193A BSN

1.53e-031171244EFO_0004337, EFO_0004784
Diseaseserum gamma-glutamyl transferase measurement

CALD1 CAMK2G SPECC1L FBXL19 SLC9A2 MAP1S TJP1 HACE1 PCIF1 CHEK2 LSM14B

1.67e-0391412411EFO_0004532
Diseasemean reticulocyte volume

AFF3 BCL11A SPECC1L CBFA2T3 E2F8 KANSL1 KLF13 PCIF1 CHEK2 LSM14B

2.05e-0379912410EFO_0010701
DiseaseProfound Mental Retardation

APC CIC SHANK2 KANSL1

2.86e-031391244C0020796
DiseaseMental Retardation, Psychosocial

APC CIC SHANK2 KANSL1

2.86e-031391244C0025363
DiseaseMental deficiency

APC CIC SHANK2 KANSL1

2.86e-031391244C0917816
DiseaseBMI-adjusted waist-hip ratio, physical activity measurement

NKX2-6 EYA1 KLF13

3.10e-03691243EFO_0007788, EFO_0008002
DiseaseOsteoarthritis of hip

FILIP1 DMP1

3.17e-03201242C0029410
DiseaseAdenocarcinoma of prostate

AXIN1 CHEK2

3.17e-03201242C0007112
Diseaseneurodegenerative disease (implicated_via_orthology)

MARK1 BCL11A NFKB2 MARK2

3.33e-031451244DOID:1289 (implicated_via_orthology)
Diseasediaphragmatic hernia

CALD1 PHF1

3.49e-03211242EFO_0008561
Diseaseage at menarche

HIP1 ASPHD1 AFF3 CHD2 PSMG3-AS1 PTPRG HACE1 BSN

3.69e-035941248EFO_0004703
Diseasephysical activity measurement

APC CIR1 BCL11A PACS1 KANSL1

3.83e-032451245EFO_0008002
DiseaseOvarian Serous Adenocarcinoma

MARK1 ALK

4.18e-03231242C1335177

Protein segments in the cluster

PeptideGeneStartEntry
RFREVPSSGERGEKG

PTPRG

776

P23470
KPTRRTERTSAGDGA

AFF3

586

P51826
VPRARRFSSGGEEDD

ABLIM3

496

O94929
GGKRRRDDISVDSLD

PPP2R2C

396

Q9Y2T4
ETDLKATGRDSFPRG

BDP1

1061

A6H8Y1
PAEKRSSGERARETG

AKAP1

186

Q92667
EEPDNGDDRGSRRTT

AGPAT4-IT1

51

Q9H0P7
KPTGARTFGERSVSR

BUB1

546

O43683
SGAARAPRSEEDKRR

CASZ1

71

Q86V15
RARRGSSSDEEGGPK

AKAP12

691

Q02952
SSRKESRGGPSRRGV

ABHD16A

166

O95870
SEGIPSIERSRKGSS

SPECC1L

371

Q69YQ0
RKGDSPRSISETGDE

BRPF3

396

Q9ULD4
STSRKRPREGEAEGA

CHEK2

516

O96017
RPREGEAEGAETTKR

CHEK2

521

O96017
KEDERGEGRPRSIVS

CAMSAP1

611

Q5T5Y3
DGVLGSRSPRTEESK

FAM193A

376

P78312
ETGARSGPRAEVETK

ARMCX4

76

Q5H9R4
VRGLGSEAKEEAPRS

CNR2

321

P34972
RNGRRPARGSSGEKE

FBXL19

351

Q6PCT2
DSESRKRTIGSGEPG

RBM26

486

Q5T8P6
ESKERRASDGSRSPT

PDZRN3

836

Q9UPQ7
GDSVRGGRSEQPKAR

NKX2-6

116

A6NCS4
SAPDKEAGRERRALS

NPFFR2

21

Q9Y5X5
EKGEPERRGRSATGR

TSPOAP1

1556

O95153
PDGRRSRGEIIDFSK

KAT6B

446

Q8WYB5
KRSPTTRGDAGEEEE

KIAA0513

321

O60268
RGGSRAPEVSDARKR

ATOH8

96

Q96SQ7
EESADARAPSGKVRR

FLII

461

Q13045
GPGRAESKESVGSRD

MAP1S

466

Q66K74
EEGAAEPALTRKGAR

MAGEF1

46

Q9HAY2
SGADERDTRRKAGPA

MAP6

231

Q96JE9
AAERVESAETRGPGK

PSMG3-AS1

111

Q96PY0
EPGSSASFGKRRKER

RNGTT

211

O60942
PGAEGEEGTTTVRKR

MEPCE

506

Q7L2J0
VEDARGKRRSSLDGS

GPR162

246

Q16538
AKVRSFGTEDRPTDR

LSM14B

41

Q9BX40
GSFSVERGPRKERET

ASPHD1

6

Q5U4P2
GDADGASSRKRTPAA

JPH4

201

Q96JJ6
GRAAREKPLSASDGE

BSN

1446

Q9UPA5
GRPSSKEGRRSDTCE

BCL11A

731

Q9H165
GTARDRSGDKDLPSL

FGFRL1

421

Q8N441
PIKDSDSDRLRRGSD

EYA1

286

Q99502
TGTRESKPDALAGRQ

HACE1

421

Q8IYU2
RASKDGGAEAPRESR

EHBP1L1

1216

Q8N3D4
RTSGSKTGRETEAAP

KANSL1

1066

Q7Z3B3
SRDTGLSQPRRDSKG

DMP1

301

Q13316
GKRRTPDRTKENGSD

CBFA2T3

291

O75081
SASRESLVKGRAGPD

SMPD3

296

Q9NY59
TREEPGKGLTAEAAR

INSM2

56

Q96T92
AARKRRESPEGDSFV

NKD2

11

Q969F2
AASVRGRSIPGAAEK

GTSE1

221

Q9NYZ3
IKGARRAPDSSSEFG

GPR84

301

Q9NQS5
PGERRREGDKRDASS

PACS1

831

Q6VY07
PGSGSRKAEAERKRD

OTUD3

11

Q5T2D3
ERDSSEPRDEGGGRK

CXXC1

96

Q9P0U4
AKDRDSGREQGPSRE

PCIF1

686

Q9H4Z3
AKSRTREPAGERGSK

E2F8

591

A0AVK6
EEASSGSESGSPKRR

CHD2

126

O14647
LRGGEASERKRPDSG

DLL1

681

O00548
GDREKSATESTPGER

CHD3

1636

Q12873
GIKGETSTATPRRSD

AXIN1

51

O15169
VKPADSESRGGRDRK

CELF5

121

Q8N6W0
DSDQPSRKRRPSGSE

CTR9

1086

Q6PD62
RTKDASSQEGRDPGR

DNAAF8

111

Q8IYS4
KRREEGPAETVGSEA

DIDO1

191

Q9BTC0
RGRGRRTSEEDTPKK

ING5

141

Q8WYH8
VRRDPSEGEASGRTD

MARK1

661

Q9P0L2
RPEEDRESGRKASST

MARK2

436

Q7KZI7
RPKLDEEAVGRSSGS

MAST2

981

Q6P0Q8
ASEKPREGTGKSRRA

MIDEAS

1001

Q6PJG2
REGTGKSRRALPFSE

MIDEAS

1006

Q6PJG2
ETRTEAGAETRSPGK

DDX24

276

Q9GZR7
AERREGAAARKARTP

KLF13

81

Q9Y2Y9
GAGGRRERRKPSSEE

FHOD1

346

Q9Y613
PSSEEGKRSRRSLEG

FHOD1

356

Q9Y613
GEPTAAATARRSKRE

PWWP2B

221

Q6NUJ5
SARPSRSKRGGEERV

SAMD1

311

Q6SPF0
SRGSPRKAATDGADT

PPP1R13L

81

Q8WUF5
DEDLKGRVPEGRSSR

CAMK2G

391

Q13555
ASRRTGDEKGVEAIP

MIER1

231

Q8N108
SSSDFEEGPSRKRPR

JARID2

96

Q92833
AARGSRSREPSPKTE

MAP3K14

361

Q99558
SSEGPDLRGRDKRGT

LST1

66

O00453
GELSDTPKGERSSRL

PHF1

291

O43189
ASSKSRPRTDGERIG

GPRASP1

451

Q5JY77
IDSTKSRSRDGRGPG

RUSC2

81

Q8N2Y8
RATGRGARKAGSEPE

RUSC2

756

Q8N2Y8
PKRRGSSGSVDETLF

RTN4

176

Q9NQC3
ESTSSENSGRRRKGP

UTY

1011

O14607
QGRSKEGKSRPRTGE

RELL2

146

Q8NC24
DSRDGDGPVREATVK

SUMF2

46

Q8NBJ7
RSEGPAKTAEGAARS

TATDN2

226

Q93075
RPRDSGRLDKASPDS

TBX3

421

O15119
SRRRAEAGDAVVAKP

TIMM29

11

Q9BSF4
SRGSSPTRVLDEGKV

MIA3

1741

Q5JRA6
TRGRSRKGSELTCPE

FILIP1

611

Q7Z7B0
TARLGDPSGRTKERE

YARS2

116

Q9Y2Z4
ARPKTDARAVGGARS

GPRASP2

96

Q96D09
REIVESGRGTASPKE

HIP1

846

O00291
DDGSDDRPAGTRSVR

PDLIM3

261

Q53GG5
DLKDRPARDGATVSR

SCARF1

451

Q14162
TIRATAEKPGGARTE

SHANK2

36

Q9UPX8
RRDSSGGTKDGDRPK

PRKAB1

21

Q9Y478
SSSELKAGRPEARGS

ALK

76

Q9UM73
SRPGGRASVDTKEAE

CALD1

511

Q05682
SGEFEKRDTIPTEGR

APC

1681

P25054
GGRRAEAKETEPESL

APOBR

926

Q0VD83
SGRAAGDTPERKEAA

CIC

1311

Q96RK0
PEKRGSERKEGSSRS

CIR1

366

Q86X95
TGKDGARRGTQSPER

STK35

136

Q8TDR2
SSGEPARESRSKTEG

USP42

961

Q9H9J4
RSKPRDQREEAGSSD

TTLL8

231

A6PVC2
RRRSSDEDAAGEPKA

POLR3C

201

Q9BUI4
RASEPGSRKARFGSE

SLC9A2

796

Q9UBY0
GDRETTIRGKATPAE

PWP2

251

Q15269
EAGADKRSPRRASAA

SPAG1

411

Q07617
GGGTRKATREDRPFR

ZNF646

1286

O15015
SDFSERRERREGPGS

PRRC2B

1381

Q5JSZ5
KGGPEREDSSRKLRT

ARHGAP31

801

Q2M1Z3
RKSLGSTEGESESRP

RGS14

286

O43566
REPGTGRKDDDVASI

MYO18B

2546

Q8IUG5
GSLRSRDEERISKPG

TJP1

336

Q07157
GGPREEAAATVRKED

WNK2

141

Q9Y3S1
IAGGDKTERRDSPRA

XKR5

336

Q6UX68
KTERRDSPRATDLAG

XKR5

341

Q6UX68
KSGLPSDRFSAERTG

TRBV7-2

76

A0A1B0GXF2
EKAERGEGASRSPRG

SORCS1

116

Q8WY21
AASDIEPESRGRRLG

VSIG10L2

651

P0DP72
ARPSSGTKEKGGRRD

ZMYND15

576

Q9H091
AEGRSSEGRKERTAE

nan

26

Q96M66
ERDSDDERPSFGGKR

TFIP11

56

Q9UBB9
DAQRDKSGRPSGRFS

TRBV7-4

71

A0A1B0GX95
TVRSTGPAKSRDGER

TRIM28

191

Q13263
TSPDRGSRDRKSGGR

ZC3H18

851

Q86VM9
REASPGSTRRDAKGG

ZNF541

636

Q9H0D2
SVPETRGRDKGSAAL

MZT2A

101

Q6P582
SGRSSKNRDGGERRP

NDE1

291

Q9NXR1
KNRDGGERRPSSTSV

NDE1

296

Q9NXR1
DSEGPEKDTRSSFRG

NFKB2

716

Q00653